top of page

Exclusive, fully-licensed, UK medical cannabis distribution platform with national WDA(H) authorization for £500k

Licensed UK medical cannabis distribution company offering national distribution authorization, robust supply chain infrastructure, and a proven team ready to trade in September 2025—strategically positioned for rapid growth!

Listing ID:

34453837192

Licence(s) Held:

UK Wholesale Distribution Authorization (WDA(H)) License Secured (Authorisation Number UK WDA(H) 60150); Controlled Drugs (CD) License inspection complete, pending Home Office approval in August 2025

UK flag with cannabis leaves for a licensed medical cannabis distributor.

Seeking strategic partner for full acquisition, partial acquisition, or equity investment; company valuation £500,000

Listing Details:

  • Pre-revenue, fully-licensed UK cannabis distribution platform with operational readiness and national coverage, set to launch September 2025

  • Office and 3PL facility established for secure import, storage, and pharmacy distribution

  • Wholesale trading supported by established relationships with all UK industry Procurement Managers

  • Platform designed to support further licenses, including Manufacturing, Clinic, and Pharmacy, for building a fully integrated medical cannabis company

  • Plans for proprietary product development focused on non-flower formulations manufactured in the UK from imported bulk materials

  • Scalable roadmap includes expansion of licensed MS facility for increased import control, higher margins, and production of own non-flower product line

  • Lean, compliant operation supported by a team of UK market operations & sales experts, QA, compliance, and operations staff

  • Pre-positioned to capture growth in the UK medical cannabis market, currently estimated at up to 100,000 patients and expanding

  • Backed by founders with deep industry experience since 2018, with proven track record across cultivation, clinical services, regulatory compliance, and multi-million-pound ventures

  • Strategic equity partner could gain control of the UK distribution chain for proprietary products or invest in a high-growth, first-mover platform

  • Clear use of funds: license upgrades, operational scale-up, branded product launch, QA systems, and working capital

  • Seeking a full acquisition, part acquisition, or investment at a company valuation of £500,000

34453837192

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal

NEW CANNABIS BUSINESSES FOR SALE

See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.

Cannabis New/Featured Business Listing - Merger & Acquisition

36324927098

Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner

Cannabis New/Featured Business Listing - Merger & Acquisition

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential

Cannabis New/Featured Business Listing - Merger & Acquisition

38939049737

4,800 sq ft licensed, micro-cultivation facility in AB for $500k

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a turnkey, fully built, turnkey 4,800 sq ft micro-cultivation facility in AB, offered at a significant discount to replacement cost

Cannabis New/Featured Business Listing - Merger & Acquisition

29345918591

State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.

bottom of page